(Q40135901)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alex Starr

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ami Citri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Simona Corso

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Silvia Giordano

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

K Shtiegman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

B S Kochupurakkal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Y Zwang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A Vexler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

M Katz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

S Lavi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Y Ben-Basat

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

S Benjamin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

J Gan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

R B Yosef

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Y Yarden

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

7 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

6968-6978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Negative receptor signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

The ErbB receptor tyrosine family as signal integrators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Association of ErbB2 Ser1113 phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Clathrin-independent endocytosis of ubiquitinated cargos

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Ligand-induced transformation by a noninternalizing epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Regulation of receptor tyrosine kinase signaling by endocytic trafficking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210503

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486068%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 December 2019

1049185901

0 references

1 reference